CRA国际 CRAI 深 沪
已收盘 08-07 16:00:00 美东时间
169.31
-7.150
-4.05%
华盛通- 最 高176.75
- 今 开174.31
- 成交量 23.12万股
- 最 低 168.66
- 昨 收 176.46
- 总市值 10.94亿
- 52周最高 226.15
- 市盈率 静 20.79
- 换手率 3.58%
- 52周最低 131.60
- 委 比 -73.91%
- 总股本 646.39万
- 历史最高 226.15
- 量 比 1.33
- 振 幅 4.58%
- 历史最低 1.38
- 每 手 1
- 风险率 21.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CRA Intl Raises FY2026 Sales Guidance from $785.000M-$805.000M to $805.000M-$820.000M vs $801.210M Est
CRA Intl (NASDAQ:CRAI) raises FY2026 sales outlook from $785.000 million-$805.000 million to $805.000 million-$820.000 million vs $801.210 million estimate.
08-06 20:14
CRA Intl Q2 Adj. EPS $2.16 Beats $2.15 Estimate, Sales $210.815M Beat $198.903M Estimate
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $2.16 per share which beat the analyst consensus estimate of $2.15 by 0.47 percent. This is a 14.89 percent increase over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $210.815 million which b...
08-06 20:11
BriaCell Therapeutics Engages Charles River Associates, Kaleio To Explore Commercial Strategy, Market Access Evaluation Of Bria-IMT
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced that it has engaged Charles River Associates (CRA) (NASDAQ:CRAI) and Kaleio, Inc. to support co...
07-07 19:32
CRA International shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results.
CRA International shares are trading lower after the company reported worse-tha...
05-08 00:37
CRA Intl Affirms FY2026 Sales Guidance of $785.000M-$805.000M vs $794.464M Est
CRA Intl (NASDAQ:CRAI) affirms FY2026 sales outlook from $785.000 million-$805.000 million to $785.000 million-$805.000 million vs $794.464 million estimate.
05-07 20:18
CRA Intl Q1 Adj. EPS $1.99 Misses $2.02 Estimate, Sales $200.975M Beat $193.819M Estimate
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $1.99 per share which missed the analyst consensus estimate of $2.02 by 1.49 percent. This is a 10.36 percent decrease over earnings of $2.22 per share from the same
05-07 20:17
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
Barrington Research Maintains Outperform on CRA Intl, Maintains $245 Price Target
Barrington Research analyst Kevin Steinke maintains CRA Intl (NASDAQ:CRAI) with a Outperform and maintains $245 price target.
03-03 04:51
CRA Intl Sees FY2026 Sales $785.000M-$805.000M vs $772.457M Est
CRA Intl (NASDAQ:CRAI) sees FY2026 sales of $785.000 million-$805.000 million vs $772.457 million analyst estimate.
02-26 21:06
CRA Intl Q4 Earnings Report: What Investors Need to Know
CRA Intl (NASDAQ:CRAI) just disclosed its Q4 earnings on Thursday, February 26,...
02-26 21:06
